PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Bone Marrow Transplantation Unit, Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: ronram73@gmail.com.\', \'Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Allergy and Clinical Immunology Unit, Department of Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.\', \'Bone Marrow Transplantation Unit, Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.\', \'Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Endocrinology Laboratory, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.\', \'Bone Marrow Transplantation Unit, Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel.\', \'Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Hematology Ward, Shamir Medical Center (Assaf Haraofeh), Zerifin, Israel.\', \'Bone Marrow Transplantation Unit, Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel; Infectious Diseases Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2666-6367(21)01027-710.1016/j.jtct.2021.06.024
?:hasPublicationType
?:journal
  • Transplantation and cellular therapy
is ?:pmid of
?:pmid
?:pmid
  • 34214738
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all